125 related articles for article (PubMed ID: 7956313)
1. Ocular inflammation stimulated by the immunomodulator AS101 [ammonium trichloro(dioxyethelene-O-O') tellurate].
Dastgheib K; Hikita N; Sredni B; Albeck M; Sredni D; Nussenblatt RB; Chan CC
Curr Eye Res; 1994 Aug; 13(8):603-10. PubMed ID: 7956313
[TBL] [Abstract][Full Text] [Related]
2. Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyethylene-O-O')tellurate (AS101).
Kalechman Y; Sotnik-Barkai I; Albeck M; Sredni B
Cancer Res; 1993 Apr; 53(8):1838-44. PubMed ID: 8467503
[TBL] [Abstract][Full Text] [Related]
3. Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-0-0')tellurate.
Kalechman Y; Zuloff A; Albeck M; Strassmann G; Sredni B
Blood; 1995 Mar; 85(6):1555-61. PubMed ID: 7888674
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of the immunomodulator AS101 on B7-1 and B7-2 costimulatory molecules: role in the antitumoral effects of AS101.
Kalechman Y; Sredni B
J Immunol; 1996 Jul; 157(2):589-97. PubMed ID: 8752906
[TBL] [Abstract][Full Text] [Related]
5. Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention.
Kalechman Y; Gafter U; Gal R; Rushkin G; Yan D; Albeck M; Sredni B
J Immunol; 2002 Jul; 169(1):384-92. PubMed ID: 12077268
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of interleukin-10 by the immunomodulator AS101 reduces mesangial cell proliferation in experimental mesangioproliferative glomerulonephritis: association with dephosphorylation of STAT3.
Kalechman Y; Gafter U; Weinstein T; Chagnac A; Freidkin I; Tobar A; Albeck M; Sredni B
J Biol Chem; 2004 Jun; 279(23):24724-32. PubMed ID: 15001575
[TBL] [Abstract][Full Text] [Related]
7. Ammonium trichloro(dioxoethylene-o,o')tellurate (AS101) sensitizes tumors to chemotherapy by inhibiting the tumor interleukin 10 autocrine loop.
Sredni B; Weil M; Khomenok G; Lebenthal I; Teitz S; Mardor Y; Ram Z; Orenstein A; Kershenovich A; Michowiz S; Cohen YI; Rappaport ZH; Freidkin I; Albeck M; Longo DL; Kalechman Y
Cancer Res; 2004 Mar; 64(5):1843-52. PubMed ID: 14996748
[TBL] [Abstract][Full Text] [Related]
8. Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101.
Sredni B; Tichler T; Shani A; Catane R; Kaufman B; Strassmann G; Albeck M; Kalechman Y
J Natl Cancer Inst; 1996 Sep; 88(18):1276-84. PubMed ID: 8797767
[TBL] [Abstract][Full Text] [Related]
9. The protective role of ammonium trichloro(dioxoethylene-O,O')tellurate in combination with several cytotoxic drugs acting by different mechanisms of action.
Kalechman Y; Shani A; Sotnik-Barkai I; Albeck M; Sredni B
Cancer Res; 1993 Dec; 53(24):5962-9. PubMed ID: 8261410
[TBL] [Abstract][Full Text] [Related]
10. Increased DNA repair ability after irradiation following treatment with the immunomodulator AS101.
Kalechman Y; Shani A; Albeck M; Sotnik Barkai I; Sredni B
Radiat Res; 1993 Nov; 136(2):197-204. PubMed ID: 8248476
[TBL] [Abstract][Full Text] [Related]
11. Novel involvement of the immunomodulator AS101 in IL-10 signaling, via the tyrosine kinase Fer.
Hayun R; Shpungin S; Malovani H; Albeck M; Okun E; Nir U; Sredni B
Ann N Y Acad Sci; 2007 Jan; 1095():240-50. PubMed ID: 17404037
[TBL] [Abstract][Full Text] [Related]
12. Radioprotective effects of the immunomodulator AS101.
Kalechman Y; Albeck M; Oron M; Sobelman D; Gurwith M; Seghal SN; Sredni B
J Immunol; 1990 Sep; 145(5):1512-7. PubMed ID: 2384668
[TBL] [Abstract][Full Text] [Related]
13. Induction of acute phase proteins in mice and humans by treatment with AS101, an immunomodulator with radioprotective properties.
Kalechman Y; Shani A; Albeck M; Sredni B
Immunopharmacology; 1995 Mar; 29(2):149-58. PubMed ID: 7539780
[TBL] [Abstract][Full Text] [Related]
14. Delay in the onset of systemic lupus erythematosus following treatment with the immunomodulator AS101: association with IL-10 inhibition and increase in TNF-alpha levels.
Kalechman Y; Gafter U; Da JP; Albeck M; Alarcon-Segovia D; Sredni B
J Immunol; 1997 Sep; 159(6):2658-67. PubMed ID: 9300685
[TBL] [Abstract][Full Text] [Related]
15. The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent.
Sredni B; Albeck M; Kazimirsky G; Shalit F
Int J Immunopharmacol; 1992 May; 14(4):613-9. PubMed ID: 1521929
[TBL] [Abstract][Full Text] [Related]
16. The tellurium redox immunomodulating compound AS101 inhibits IL-1β-activated inflammation in the human retinal pigment epithelium.
Ling D; Liu B; Jawad S; Thompson IA; Nagineni CN; Dailey J; Chien J; Sredni B; Nussenblatt RB
Br J Ophthalmol; 2013 Jul; 97(7):934-8. PubMed ID: 23624272
[TBL] [Abstract][Full Text] [Related]
17. The effect of the novel tellurium compound AS101 on autoimmune diseases.
Halpert G; Sredni B
Autoimmun Rev; 2014 Dec; 13(12):1230-5. PubMed ID: 25153485
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation by ammonium trichloro(dioxoethylene-0,0') tellurate (AS101) of Fas/Apo-1 expression on B16 melanoma cells: implications for the antitumor effects of AS101.
Kalechman Y; Strassmann G; Albeck M; Sredni B
J Immunol; 1998 Oct; 161(7):3536-42. PubMed ID: 9759874
[TBL] [Abstract][Full Text] [Related]
19. The immunomodulator AS101 induces growth arrest and apoptosis in multiple myeloma: association with the Akt/survivin pathway.
Hayun M; Naor Y; Weil M; Albeck M; Peled A; Don J; Haran-Ghera N; Sredni B
Biochem Pharmacol; 2006 Nov; 72(11):1423-31. PubMed ID: 16889755
[TBL] [Abstract][Full Text] [Related]
20. The immunomodulator, ammonium trichloro[1,2-ethanediolato-O,O']-tellurate, suppresses the propagation of herpes simplex virus 2 by reducing the infectivity of the virus progeny.
Sheinboim D; Hindiyeh M; Mendelson E; Albeck M; Sredni B; Dovrat S
Int J Mol Med; 2015 Jul; 36(1):231-8. PubMed ID: 25936393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
